[Sign in] [Register]   

EIAab logo

Index > News Center > News list.
Enter your KeyWord (Ex. ELISA Kit, Cuticular Active Peptide Factor, etc)
Search content in infomation.

EIAab attend the 32 th JACBS in Taiwan

Posted by star on 2017-03-23 00:26:07

On March 25 to 26 ,The JACBS will be held in Taiwan,We pay highly attention to this meeting and send our staffs to attend it .it is a good chance for us to know the newest information about the bio-tech and will push us to move advance with times!

EIAab will be showed on the Annual AACR in the USA

Posted by star on 2017-03-23 00:25:29

On April 1 , the AACR Annual will be held in Washington .Our agents will attend the meeting on behalf of EIAab .Our brand will be showed on the international arena again ,which meants a lot for us to promote our brand to the world.

EIAab&ARP&2B Science hold a friendly business meeting

Posted by star on 2017-03-21 00:16:46

    On march 17 ,2017.Our sales Mr.Li and Mrs.May hold a business meeting on a business hotel. Our good friends--Mr.DAN (ARP)and Mr.Tim (2B Science ) attend the meeting .
    During the meeting ,we have a nice communication about the bio-marking and business cooperation issues and reach a win-win consensus with each other.which laying the necessary foundation of building a further cooperation relationship in the future .

The visit from ARP in the US

Posted by star on 2017-03-15 23:41:20

The CEO of ARP in the US Mr. Dan had a visit to EIAAB on March 13, 2017. Mr. Dan received a warm welcome from us.

Accomplished by EIAAB members, Mr. Dan visited the R&D department and production department. During the following meeting, we had a business talk friendly. In future cooperation we will be the only Chinese supplier for them.

The risk of hip fracture associated with diabetes is attenuated when accounting for mortality risk in patients, according to research published in the Journal of Clinical Endocrinology & Metabolism.

Emma Hamilton, from the School of Medicine and Pharmacology, University of Western Australia in Crawley, and colleagues analyzed the risk for hip fracture among 1291 patients from the Fremantle Diabetes Study Phase I (FDS1) with type 2 diabetes and compared them with a matched group of 5159 patients without diabetes. Mean age was 64 ± 11.2 years, 48.7% were men, 1.5% of patients (n=19) had been hospitalized for hip fracture prior to the start of the study, and median diabetes duration was 4.0 years.


“[W]e found that the risk of incident hip fracture in our patients with type 2 diabetes was at the lower end of the range found in other studies employing conventional statistical methods, perhaps reflecting the multiracial, population-based nature of the FDS1 cohort and the validated categorization of diabetes type,” Watson and colleagues wrote. “However, the risk of hip fracture in our patients with diabetes was attenuated to nonsignificance after allowing for the competing risk of death.”

The researchers found the first hip fracture incident rate ratio (IRR) was 1.33 (95% CI, 1.05-1.68;P =.013) for patients with type 2 diabetes compared with the control group, with an age-, gender-, and comorbidity-adjusted cause-specific hazard ratio (HR) of 1.50 (95% CI, 1.19-1.89; P <.001) and subdistribution HR of 1.21 (95% CI, 0.96-1.52; P =.11) for patients with type 2 diabetes. 

Hamilton and colleagues also found that the use of insulin and renal impairment P ≤.015) were associated with cause-specific ......

Page 9 of 75
Hot Genes
ALCAM ACE KSR2 ASPRO C19orf80 Gdf5 Trap1a Atf2
Top Searches
Ubiquitin ELISA Ubiquitin-protein ligase Asprosin metalloproteinase TRAP1A Tumor necrosis vitamin d
Why choose EIAAB
Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
Further Information
About us Protein center Bank account Distributors Terms & Conditions Career

Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab